Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Quang Bui

Cardiovascular Disease Philadelphia, PA Medical Doctor

NPI 1346302957 CMS profile 243005

3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104

Open in the dashboard

General payments

$933,298

1,752 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Quang Bui of Philadelphia, PA is reported in the CMS Open Payments database as having received $933,298 across 1,752 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80,114 175
2024 General $150,912 311
2023 General $117,283 232
2022 General $121,349 226
2021 General $187,583 286
2020 General $136,868 220
2019 General $139,190 302

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Quang Bui
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Quang Bui were reported at $80,114. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Quang Bui Cardiovascular Disease median Middle half National median
2019 $139,190 $450 $127–$1,392 $163
2020 $136,868 $242 $77–$751 $114
2021 $187,583 $335 $101–$1,037 $132
2022 $121,349 $395 $121–$1,211 $149
2023 $117,283 $443 $136–$1,283 $160
2024 $150,912 $450 $136–$1,323 $164
2025 $80,114 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $897,204 825 payments
  2. Boston Scientific Corporation $9,237 231 payments
  3. Shockwave Medical, Inc $7,321 18 payments
  4. Abiomed $3,976 87 payments
  5. Medtronic, Inc. $3,617 257 payments
  6. Nihon Kohden America, Inc. $1,901 1 payment
  7. Philips Electronics North America Corporation $1,722 42 payments
  8. Abbott Laboratories $1,219 58 payments
  9. W. L. Gore & Associates, Inc. $791 16 payments
  10. Medtronic Vascular, Inc. $788 62 payments
  11. Other $5,523 155 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $679,273 171 payments
  2. Honoraria $106,737 41 payments
  3. Travel and Lodging $104,209 382 payments
  4. Food and Beverage $36,351 1,155 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $6,600 1 payment
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100 1 payment
  7. Gift $28 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $623,154 444 payments
  2. Edwards SAPIEN 3 Transcatheter Heart Valve $266,890 247 payments
  3. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $7,015 10 payments
  4. SAPIEN 3 Ultra RESILIA $4,276 71 payments
  5. Impella $3,760 84 payments
  6. Micra $2,906 220 payments
  7. CROSSBOSS $1,480 8 payments
  8. AVVIGO Guidance System $1,430 17 payments
  9. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $1,029 22 payments
  10. Emerge Push $775 7 payments
  11. Other $16,267 605 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,752 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record